News content

China Oriental Group has increased the tender price on its offer to repurchase all or a portion of its dollar-denominated bonds.

Amgen, the US multinational bio-pharmaceutical company, on Monday announced plans for its debut bond in Swiss francs, a transaction that bankers hope could turn a gloomy February market around.

The syndicate for Akbank’s bellwether one year loan refinancing could change as geopolitical and liquidity concerns affect banks’ appetite for the tightly priced Turkish loan.

Commerzbank posted stellar results on Friday, sending its stock soaring in a week where fears about the banking system ravaged markets. And though the investment bank saw revenues fall, Michael Reuther, its chief, told GlobalCapital exclusively that the division is set to increase its client base, and even enter some new markets.

Samsung Engineering’s W1.27tr ($1.06bn) rights issue has been 99.9% covered, with the remainder to be sold to the public, according to a source close to the deal.

Ranhill Holdings remains undecided on when to open books for its MR807.5m ($195.94m) Malaysian IPO and is taking a day-by-day approach on the launch due to volatile market conditions, said sources.

GMR Infrastructure and IRB Infrastructure Developers are seeking separate approvals from India’s stock market regulator to launch the country’s first publicly listed infrastructure investment trusts (InvITs).

Hong Kong blue chip Sun Hung Kai Properties has wrapped up a HK$15bn ($1.93bn) refinancing with 17 banks coming in for a piece of the deal.

Baring Private Equity Asia has tapped five banks to helm a $400m loan to back its bid for Singapore-based Interplex Holdings, with the deal to open into general syndication shortly.

Following a four year absence, South Korean lender Busan Bank has finally kicked off preparations for a dollar comeback which is scheduled for the second half of the year. However, the bank is still mulling over the best format to issue in.

Tritax Big Box Reit, a UK logistics real estate investment trust, closed a £200m follow-on capital raising on Friday morning, having increased the deal from a £100m-£150m range.

Chinese pharmaceutical company Hutchison China MediTech (Chi-Med) has picked a quartet of co-managers for a $100m listing on the Nasdaq.